Search research articles
Contact Us
Filters
Showing results (251-260 of 578) with videos related to
Page
of 58
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2009
Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes
Kristel Van Calsteren, Liesbeth Heyns, Frank De Smet, et al.
Anticancer Research
|
November 10, 2019
Increased Immunosuppression Is Related to Increased Amounts of Ascites and Inferior Prognosis in Ovarian Cancer
A N Coosemans, Thais Baert, Victoria D'Heygere, et al.
Cancers
|
December 10, 2021
Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer-A Study of the OVCAD Consortium
Eva Obermayr, Elena Ioana Braicu, Stephan Polterauer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 31, 2018
Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study
Elisabeth Maritschnegg, Florian Heitz, Nina Pecha, et al.
Breast Cancer Research and Treatment
|
May 21, 2019
Tumor characteristics and outcome by androgen receptor expression in triple-negative breast cancer patients treated with neo-adjuvant chemotherapy
Lynn Jongen, Giuseppe Floris, Hans Wildiers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2007
External validation of mathematical models to distinguish between benign and malignant adnexal tumors: a multicenter study by the International Ovarian Tumor Analysis Group
Caroline Van Holsbeke, Ben Van Calster, Lil Valentin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer
Giorgio Bogani, Robert L Coleman, Ignace Vergote, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 15, 2023
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer
Giorgio Bogani, Robert L Coleman, Ignace Vergote, et al.
Journal of the National Cancer Institute
|
January 17, 2003
International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma
J Baptist Trimbos, Mahesh Parmar, Ignace Vergote, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 9, 2016
Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients
Ignace Vergote, Susana Banerjee, Anne-Marie Gerdes, et al.
Page
of 58
Search research articles
Search
Showing results (251-260 of 578) with videos related to
Sort By:
Page
of 58
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2009
Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes
Kristel Van Calsteren, Liesbeth Heyns, Frank De Smet, et al.
Anticancer Research
|
November 10, 2019
Increased Immunosuppression Is Related to Increased Amounts of Ascites and Inferior Prognosis in Ovarian Cancer
A N Coosemans, Thais Baert, Victoria D'Heygere, et al.
Cancers
|
December 10, 2021
Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer-A Study of the OVCAD Consortium
Eva Obermayr, Elena Ioana Braicu, Stephan Polterauer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 31, 2018
Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study
Elisabeth Maritschnegg, Florian Heitz, Nina Pecha, et al.
Breast Cancer Research and Treatment
|
May 21, 2019
Tumor characteristics and outcome by androgen receptor expression in triple-negative breast cancer patients treated with neo-adjuvant chemotherapy
Lynn Jongen, Giuseppe Floris, Hans Wildiers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2007
External validation of mathematical models to distinguish between benign and malignant adnexal tumors: a multicenter study by the International Ovarian Tumor Analysis Group
Caroline Van Holsbeke, Ben Van Calster, Lil Valentin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer
Giorgio Bogani, Robert L Coleman, Ignace Vergote, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 15, 2023
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer
Giorgio Bogani, Robert L Coleman, Ignace Vergote, et al.
Journal of the National Cancer Institute
|
January 17, 2003
International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma
J Baptist Trimbos, Mahesh Parmar, Ignace Vergote, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 9, 2016
Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients
Ignace Vergote, Susana Banerjee, Anne-Marie Gerdes, et al.
Page
of 58